Lipolysis-stimulated receptor: a newcomer on the lipoprotein research scene.
It has been widely accepted that the remnants of the intestinally-derived lipoprotein chylomicrons, i.e., chylomicron remnants (CMR), are cleared from the circulation by a receptor genetically distinct from the well-known LDL-receptor. This second receptor was initially considered as a receptor specific for apo E, in contrast to the LDL-receptor, which binds both apo B and apoE. This article critically examines the current dogma of the putative CMR receptor, as well as both supporting and conflicting evidence for the recently-proposed identity of this receptor with the LDL-receptor related protein (LRP). Next, we introduce the lipolysis-stimulated receptor, LSR, which bears all the biochemical characteristics of the CMR receptor. In addition, the apparent number of LSR expressed in the liver is inversely correlated with nonfasting levels of plasma triglycerides. A change in LSR expression and parallel inverse change in plasma triglycerides is observed in rats treated with hyperlipidemic (retinoic acid) or hypolipidemic (fish oil in MaxEPA) agents, indicating that LSR represents a definite target for pharmacological management of hyperlipidemia. In support of this notion is the observation that MaxEPA, which causes an increase in LSR expression, also reduces both plasma triglyceride and cholesterol levels in the thus far intractable homozygous Watanabe heritable hyperlipidemic rabbit.
Bihain
B E
BE
Inserm Unité 391, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes I, France.
Delplanque
B
B
Khallou
J
J
Chevreuil
O
O
Troussard
A A
AA
Michel
L
L
Mann
C J
CJ
Yen
F T
FT
D000818:Animals; D002914:Chylomicrons; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011971:Receptors, Immunologic / Q000032:analysis; D011973:Receptors, LDL / Q000032:analysis*; D018110:Receptors, Lipoprotein / Q000032:analysis*
D002914:Chylomicrons; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; C028203:chylomicron receptor; C085992:lipolysis-stimulated receptor